Beneficial ownership — 13D / 13G
85,680 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.
Coverage begins December 2024, when the SEC required these schedules to be filed as structured XML.
| Reporting person | Issuer | Schedule | % of class | Event date | Filed |
|---|---|---|---|---|---|
| Pelham Capital Ltd. | SHCO Soho House & Co Inc. | 13G/A | 7.4% | Dec 31, 2023 | 2y |
| Witmer Richard H. | ACCS ACCESS Newswire Inc. | 13G/A | 4.8% | Dec 31, 2023 | 2y |
| FEDERATED HERMES, INC. | RPC Ridgepost Capital, Inc. | 13G/A | 5.99% | Dec 31, 2023 | 2y |
| FEDERATED HERMES, INC. | ATYR aTYR PHARMA INC | 13G/A | 17.37% | Dec 31, 2023 | 2y |
| FEDERATED HERMES, INC. | RZLT Rezolute, Inc. | 13G/A | 19.99% | Dec 31, 2023 | 2y |
| FEDERATED HERMES, INC. | DVAX Dynavax Technologies Corporation | 13G/A | 8.79% | Dec 31, 2023 | 2y |
| MILLENNIUM MANAGEMENT LLC | EBS Emergent BioSolutions Inc. | 13G/A | 4% | Dec 31, 2023 | 2y |
| FEDERATED HERMES, INC. | MRUS Merus N.V. Common Shares | 13G/A | 6.3% | Dec 31, 2023 | 2y |
| FEDERATED HERMES, INC. | FUSN Fusion Pharmaceuticals Inc. Common Shares | 13G/A | 15.03% | Dec 31, 2023 | 2y |
| Sue Anne Wells | COKE Coca-Cola Consolidated, Inc. | 13G/A | 3.6% | Dec 31, 2023 | 2y |
| FEDERATED HERMES, INC. | IDYA IDEAYA Biosciences, Inc. | 13G/A | 6.03% | Dec 31, 2023 | 2y |
| FEDERATED HERMES, INC. | SCYX Scynexis Inc | 13G/A | 19.99% | Dec 31, 2023 | 2y |
| Witmer Richard H. | RSSS Research Solutions, Inc. | 13G/A | 8% | Dec 31, 2023 | 2y |
| Lind Global Fund II LP | FNGR FingerMotion, Inc. | 13G/A | — | Dec 31, 2023 | 2y |
| Impax Asset Management Group plc | MWA Mueller Water Products, Inc. | 13G | 7.97% | Dec 29, 2023 | 2y |
| JPMORGAN CHASE & CO | CFLT Confluent, Inc. Class A Common Stock | 13G/A | 9.8% | Dec 29, 2023 | 2y |
| Impax Asset Management Group plc | WTS Watts Water Technologies Inc | 13G | 5.15% | Dec 29, 2023 | 2y |
| JPMORGAN CHASE & CO | DOV DOVER Corp | 13G/A | 10.2% | Dec 29, 2023 | 2y |
| JPMORGAN CHASE & CO | EVH Evolent Health, Inc. | 13G/A | 5.1% | Dec 29, 2023 | 2y |
| Fiera Capital Corp | GGG Graco Inc | 13G/A | 4.38% | Dec 29, 2023 | 2y |
| JPMORGAN CHASE & CO | CPA Copa Holdings, S.A. | 13G/A | 9.5% | Dec 29, 2023 | 2y |
| Impax Asset Management Group plc | PNR PENTAIR plc | 13G | 4.9% | Dec 29, 2023 | 2y |
| JPMORGAN CHASE & CO | ETN Eaton Corp plc | 13G/A | 6.3% | Dec 29, 2023 | 2y |
| JPMORGAN CHASE & CO | PLOW Douglas Dynamics, Inc | 13G/A | 8.2% | Dec 29, 2023 | 2y |
| Impax Asset Management Group plc | ZWS Zurn Elkay Water Solutions Corp | 13G | 5.07% | Dec 29, 2023 | 2y |
| JPMORGAN CHASE & CO | ENR Energizer Holdings, Inc. | 13G/A | 7% | Dec 29, 2023 | 2y |
| VT Smart Venture Sdn Bhd | TGL Treasure Global Inc | 13G | 18.71% | Dec 19, 2023 | 2y |
| A.L. Sarroff Fund, LLC | PETV PetVivo Holdings, Inc. | 13G/A | 12.22% | Dec 6, 2023 | 2y |
| Indaba Capital Management, L.P. | ONTF ON24 INC. | 13D/A | 10.2% | Nov 8, 2023 | 2y |
| Williams & Novak, LLC | SYPR Sypris Solutions Inc | 13G/A | 18% | Oct 25, 2023 | 2y |
| GEC Tech Ltd | OMH Ohmyhome Ltd | 13G | 6.44% | Mar 21, 2023 | 2y |
| Noll Shaun | DRTTF Dirtt Environmental Solutions Ltd | 13D/A | 27.9% | Jan 9, 2023 | 2y |
| Ian McDonald | DRUG Bright Minds Biosciences Inc. | 13D | 7.57% | Aug 16, 2021 | 2y |
| SUN PHARMACEUTICAL INDUSTRIES LTD. | TARO Taro Pharmaceutical Industries Ltd. | 13D/A | 78.48% | Jan 17, 2024 | 2y |
| Atlas Investissement SAS | TIGO Millicom International Cellular SA | 13D/A | 29.14% | Jan 17, 2024 | 2y |
| Mo Chen | TSPH TuSimple Holdings Inc. | 13D/A | 19.1% | Jan 16, 2024 | 2y |
| Dragasac Ltd | CELU Celularity Inc | 13D/A | 33.6% | Jan 12, 2024 | 2y |
| Apollo Management Holdings GP, LLC | SNX Td Synnex Corp | 13D/A | 29.1% | Jan 12, 2024 | 2y |
| Yakira Capital Management, Inc. | BRAC Broad Capital Acquisition Corp Common Stock | 13G/A | 11.07% | Jan 12, 2024 | 2y |
| Iole Lucchese | SCHL Scholastic Corp | 13D/A | 5.5% | Jan 12, 2024 | 2y |
| Qatar Investment Authority | GBTG Global Business Travel Group, Inc. | 13D | 18.8% | Jan 11, 2024 | 2y |
| Millennium Management LLC | STRO Sutro Biopharma, Inc. | 13G | 5.7% | Jan 10, 2024 | 2y |
| BML Investment Partners, L.P. | OKUR OnKure Therapeutics, Inc. | 13G | 5.1% | Jan 10, 2024 | 2y |
| Yisroel Mordechai Goldstone | RENT Rent the Runway, Inc. | 13D | 8.6% | Jan 8, 2024 | 2y |
| Blacksheep Fund Management Ltd | TCX Tucows Inc | 13G/A | 8.4% | Jan 8, 2024 | 2y |
| CLEARTHINK CAPITAL PARTNERS, LLC | BSFC Blue Star Foods Corp. | 13G | 8% | Jan 5, 2024 | 2y |
| ELLINGTON MANAGEMENT GROUP LLC | OPRT Oportun Financial Corp | 13G/A | 7.26% | Dec 31, 2023 | 2y |
| MMCAP International Inc. SPC | WSTRF Western Uranium & Vanadium Corp. | 13G/A | 9.99% | Dec 31, 2023 | 2y |
| ELLINGTON MANAGEMENT GROUP LLC | RPT Rithm Property Trust Inc. | 13G/A | 6.07% | Dec 31, 2023 | 2y |
| Thomas J. Herzfeld Advisors, Inc. | OCCI OFS Credit Company, Inc. | 13G | 8.39% | Dec 31, 2023 | 2y |